Site Map     Privacy & Terms

dermaPACE® Phase III Trial Results Announced


View Technology Details, Study Design and 24-Week Top-Line Safety and Efficacy Results of SANUWAVE’s Randomized,
Double-blinded, Sham-controlled, Pivotal Clinical Trial





News

Jan 25, 2012 - SANUWAVE Technology Shown to Promote Fracture Healing by Affecting Growth of New Blood Vessels and Bone

Jan 17, 2012 - SANUWAVE Issued U.S. Patent for a New Method to Produce Acoustic Shock Waves Utilizing Pressurized Fluid

Jan 10, 2012 - PACE Technology Shown to Protect Tissues Against Ischemic and Reperfusion Injury

About SANUWAVE

A pioneer in the field of regenerative medicine, SANUWAVE specializes in the development and commercialization of
non-invasive, biological response activating devices based on the PACE® Technology platform.

Learn more about ESWT and PACE Science




Interactive PACE Mechanism of Action



Copyright © 2006-2012 SANUWAVE, Inc. All Rights Reserved. OssaTron, EvoTron, VersaTron, dermaPACE, OrthoTripsy, “Healing Today. Curing Tomorrow.” and Pulsed Acoustic Cellular Expression (PACE) are all registered trademarks of SANUWAVE.